07:30 ETPackGene to Present Advances in Scalable AAV Manufacturing, Analytical Innovation, and Novel Capsid Engineering at ASGCT 2026prnewswire·May 5, 2026 at 11:38 AMNKGN+300.00%PRTG0.00%
Rossari Biotech's (NSE:ROSSARI) Profits Appear To Have Quality IssuesSimplywall·May 4, 2026 at 09:58 AMJYBPRTG0.00%
PanGIA Biotech Non-Invasive Cancer Detection Abstracts Accepted for Presentation at AACR Annual Meeting 2026MorningStar·Apr 14, 2026 at 11:40 AMPRTG0.00%SBIO-2.14%
PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine LearningUnusual Whales·Apr 2, 2026 at 11:32 AMPRTG0.00%SBIO-2.14%
Crypto treasuries and blockchain are paving the way for decentralized scienceCointelegraph·Nov 15, 2025 at 06:04 PMPRTG0.00%
'Biggest Opportunity for Mass Adoption': TON Treasury Loads Up on Telegram-Linked CoinCoinLive·Sep 3, 2025 at 10:15 PMPRTG0.00%
AlphaTON Capital plans to raise $100 million to launch TON digital asset treasury strategyCoinLive·Sep 3, 2025 at 02:08 PMPRTG0.00%
Portage Biotech reports $6.8 million net loss in fiscal year 2025, a significant decrease from $75.4 million in fiscal year 2024. Expenses decreased in R&D and G&A categories. Company had $1.7 million in cash with $1.1 million in total current liabilities as of March 31, 2025.Unusual Whales·Jul 25, 2025 at 08:44 PMPRTG0.00%
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025 | PRTG Stock NewsStockTitan·Jul 25, 2025 at 08:15 PMPRTG0.00%ATON0.00%
Portage Biotech and Compedica Stock-for-Stock ExchangeGlobeNewswire·Jun 9, 2025 at 10:00 AMPRTG0.00%ATON0.00%
Portage Biotech's preclinical results in mesothelioma back up first human trial of PORT-7.Unusual Whales·Apr 28, 2025 at 10:18 AMPRTG0.00%
